Antimicrobial Shortages

Shortages of first-line and commonly used antimicrobials pose considerable challenges to the treatment of patients; suboptimal and delayed therapy for serious infectious diseases can compromise patient safety and result in poorer outcomes, including death.

The information gathered from sponsors, manufacturers and NSW health agencies during the risk assessment for each shortage has been summarised into medication shortage communication sheets, Safety Notices or Safety Alerts. These documents provide timely information to local health districts enabling appropriate responses to minimise risk to patient safety.

The Medicine Shortage Information Sheets have been produced by the Medicine Shortage Assessment and Management Team (MSAM) which is an interagency team consisting of members from the Clinical Excellence Commission, HealthShare NSW, Chief Pharmacist Unit and The Office of the Chief Health Officer.

Current Antimicrobial Shortages

20 October 2017
Piperacillin-tazobactam intravenous preparations

Safety Notice

NCAS factsheet

ASID factsheet